CytoMed Therapeutics (GDTC) Revenue (2020 - 2025)
CytoMed Therapeutics (GDTC) revenue from Mar 31, 2020 to Dec 31, 2025. The TTM CytoMed Therapeutics (GDTC) revenue is $494K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
CytoMed Therapeutics (GDTC) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +81.88% |
| 3 Years TTM | +46.90% |
| 5 Years TTM | +61.70% |
| All Time TTM | +60.51% |
Annual Revenue change of CytoMed Therapeutics (GDTC)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $249K | +385.37% |
| 2024 | $51K | -86.73% |
| 2023 | $387K | +40.00% |
| 2022 | $276K | +365.41% |
| 2021 | $59K | +95.92% |
| 2020 | $30K | N/A |
| 2019 | $0 | N/A |